Back to TSHA

Avoro Capital Advisors LLC → TSHA

Avoro Capital Advisors LLC TSHA Position History

Taysha Gene Therapies, Inc. • Healthcare

Quarters held
5
Latest value
$116.3M
Q3 2026
Peak value
$162.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$119.3M
Q4 2025$119.3M
Q1 2026$97M
Q2 2026$162.7M
Q3 2026$116.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$116.3M23.89M——
Q2 2026$162.7M23.89M——
Q1 2026$97M21.70M——
Q4 2025$119.3M21.70M——
Q4 2025$119.3M21.70M——

Other funds holding TSHA

Other Avoro Capital Advisors LLC positions

UTHR

UNITED THERAPEUTICS CORP

$1.6B
UTHR

UNITED THERAPEUTICS CORP

$1.5B
UTHR

UNITED THERAPEUTICS CORP

$1.5B
ASND

ASCENDIS PHARMA

$1.4B
UTHR

UNITED THERAPEUTICS CORP

$1.3B
UTHR

UNITED THERAPEUTICS CORP

$1.3B
ASND

ASCENDIS PHARMA

$1.2B
ASND

ASCENDIS PHARMA A/S

$1.2B